Clinical OMICs - Issue 5 - (Page 30)
Clinical OMICs MEETING ROUND-UP
July 27-31
August 19-21
Chicago, IL
www.aacc.org
Connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine,
lab management, and other areas
of breaking science in laboratory
medicine. Learn about cuttingedge technology with more than 200 new product introductions. Hear vital research about important changes in
the field by attending plenary sessions with different perspectives on the future of healthcare, brown bag sessions
for intimate and active discussions among participants,
and a meet the experts session for intense discussions
with plenary speakers and other invited experts.
Washington, DC
www.nextgenerationdx.com
Access to next-generation diagnostics will be gained
through creation and management of partnerships in
the community around development, commercialization,
reimbursement, and regulation. This year's Next Generation Dx Summit will showcase advances in personalized
medicine through a program encompassing companion
diagnostics, infectious disease, cancer molecular markers,
point-of-care, inherited disorders, cell-free DNA, and single-cell sequencing. The event will showcase key components of major players in the diagnostics arena and their
successful adoption in the clinic and advancement to the
market.
August 4-8
September 23-25
Bethesda, MD
www.biotrac.com
Researchers involved in clinical proteomics face numerous
methodological, analytical, and statistical challenges that
need to be addressed in order for successful completion of
projects. Large-scale biomarker discovery efforts include
the coordination of many different disciplines, such as
biochemistry, proteomics and mass spectrometry, clinical chemistry, and bioinformatics. In this course, students
will be exposed to many of the challenging aspects of
biomarker discovery projects, as well as to the numerous
analytical platforms that may be employed. Topics being
covered include study design and sample collection/storage, sample handling, and quality control and reproducibility in measurements.
Boston, MA
www.world-cdx.com
Maximize your understanding of disease heterogeneity,
validation of clinically relevant biomarkers, and co-development and commercialization of drug-CDx combinations.
This summit will deliver a multitude of interactive formats,
such as one-on-one keynote interviews, live virtual Twitter debates, breakout roundtables, panel discussions, and
more. You'll also be able to construct and develop complete biomarker strategies dealing with incorporation of
biomarkers into clinical trial design, huge datasets, and
patient stratification. The dynamic platform will provide
you with extensive opportunities to network with field
leaders and colleagues who are tackling challenges similar
to those you may be facing.
AACC Annual Meeting
Clinical Proteomics and Biomarker Discovery
Next Generation Dx Summit
World CDx Boston
City images courtesy of Wikipedia Commons: Chicago, Daniel Schwen; Bethesda, Andrew Bossi; Washington DC, USAF Tech. Sgt. Andy Dunaway; Boston,Henry Han
30
Clinical OMICs June 12, 2014
www.clinicalomics.com
http://www.nextgenerationdx.com
http://www.aacc.org
http://www.biotrac.com
http://www.world-cdx.com
http://www.clinicalomics.com
Table of Contents for the Digital Edition of Clinical OMICs - Issue 5
Contents
Clinical OMICs - Issue 5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue15
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue14
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue13
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue1
https://www.nxtbookmedia.com